The most commonly reported side effects of propoxycaine include device dislocation, deep vein thrombosis, and drug hypersensitivity, based on 6 FDA adverse event reports from 2013 to 2023.
Percentages show how often each reaction appears relative to total reports for propoxycaine.
These are voluntary reports and do not establish that propoxycaine caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside propoxycaine. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
83.3% of propoxycaine adverse event reports involve female patients and 0.0% involve male patients. The largest age group is adult at 67%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking propoxycaine when the adverse event was reported.
Propoxycaine is sold under the brand name Ravocaine And Novocain W/ Levophed.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.